logo

For the Inventor, By the Inventor

London, United Kingdom

Helperby Therapeutics Limited


USPTO Granted Patents = 18

% Expired Patents = 44.4



Forward Citations = 55

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Yanmin Hu (17 out of 17 patents)

silverMedal Anthony Coates (10 out of 10 patents)

bronzeMedal Anthony R M Coates (4 out of 4 patents)

4.  Hazel Joan Dyke (4 out of 32 patents)

5.  Thomas David Pallin (4 out of 30 patents)

6.  Marc Barry Brown (3 out of 35 patents)

7.  David Edward Clark (3 out of 26 patents)

8.  Keith Mills (3 out of 3 patents)

9.  Gary Patrick Reid (3 out of 5 patents)

10.  Petra Helga Beck (3 out of 3 patents)

11.  Gerlinda Stoddart (3 out of 3 patents)

12.  Derek John Londesbrough (3 out of 11 patents)

13.  Anthony Robert Milnes Coates (2 out of 4 patents)

14.  Anthony M R Coates (1 out of 1 patent)

15.  Mandy Christine Beswick (1 out of 5 patents)


18 patents:

1. 12594319 - Pharmaceutical development (2026-04-07),
2. 11951119 - Combination comprising zidovudine and an antimicrobial compound (2024-04-09),
3. 10888575 - Combination comprising zidovudine and a carbapenem (2021-01-12),
4. 10736888 - Triple combination (2020-08-11),
5. 10493071 - Use of pyrroloquinoline compounds to kill clinically latent microorganisms (2019-12-03),
6. 10335454 - Combination and use (2019-07-02),
7. 10265373 - Pharmaceutical composition and method of treating a microbial infection with sulcotidil (2019-04-23),
8. 10098904 - Zidovudine combination therapies for treating microbial infections (2018-10-16),
9. 9789101 - Methods and compositions for treating microbial infection using pyrroloquinone (2017-10-17),
10. 9757427 - Combination comprising zidovudine and polymyxin (2017-09-12),
11. 9694006 - Use of pyrroloquinoline compounds to kill clinically latent microorganisms (2017-07-04),
12. 9549965 - Pharmaceutical composition for treating a microbial infection (2017-01-24),
13. 9216186 - Combination of a pyrroloquinoline compound and an aminoglycodise antimicrobial agent (2015-12-22),
14. 8940723 - Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine (2015-01-27),
15. 8759348 - Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms (2014-06-24),
Company Overview
Helperby Therapeutics Limited is a biotechnology company based in London, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing advanced technologies to create treatments that address unmet medical needs, particularly in the field of infectious diseases. With a commitment to research and development, Helperby aims to leverage its expertise in drug discovery and formulation to improve patient outcomes and contribute to global health advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

18 Patents

#206 in

#1,001 in

#34,244 in the World

London, GB
London, United Kingdom

Helperby Therapeutics Limited

Forward Citations = 55

18 inventors:

goldMedal Yanmin Hu (17 out of 17 patents)

silverMedal Anthony Coates (10 out of 10 patents)

bronzeMedal Anthony R M Coates (4 out of 4 patents)

4.  Hazel Joan Dyke (4 out of 32 patents)

5.  Thomas David Pallin (4 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Helperby Therapeutics Limited. Retrieved from https://idiyas.com/company/helperby-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…